LAUREN GILMORE: Open Payments
NPI 1205373552 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 11 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $40 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Shionogi Inc | 1 | $22 |
| Route 92 Medical, Inc. | 1 | $19 |
Products named: ZERBAXA, XIFAXAN, VPRIV, ELIQUIS, Fetroja, CAMZYOS.
Industry payments across KY — which companies pay providers there.
